GUANGZHOU BAIYUNSHAN PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss
The total revenue of 874 for the last quarter is 24.85 B HKD, and it's 33.40% higher compared to the previous quarter. The net income of Q1 24 is 2.13 B HKD.